Video Shorts

0:56
Biotech Security: A New National Defense Priority
2 days ago
by
Mike Hollan(+1 more)

1:29
Exec on Execs: China's Rise in Biotech Investment
4 days ago
by
Mike Hollan

1:13
Market Movers Rx: Iqvia Leads Gainers
7 days ago
by
Nicholas Jacobus

1:53
Execs on Exec: GLP-1 Coverage Gaps, China's Supply Chain, and the Clinical Trial Competitiveness Problem
11 days ago
by
Mike Hollan

1:03
Why U.S. Biotech Regulation is Slow
11 days ago
by
Mike Hollan(+1 more)

1:19
Market Movers Rx: AbbVie Leads Gainers
14 days ago
by
Nicholas Jacobus

0:50
Why Your GLP-1 Strategy Is Failing
16 days ago
by
Mike Hollan(+1 more)

0:46
Why U.S. Manufacturing is Losing Its Competitive Edge
21 days ago
by
Nicholas Jacobus(+1 more)

0:54
Why We Need Better Drugs, Not Just More Drugs
24 days ago
by
Mike Hollan(+1 more)

1:21
Market Watch RX: Gilead Joins Top Gainers
a month ago
by
Nicholas Jacobus

0:27
The Key to AI Scale-Up
a month ago
by
Michael Christel(+1 more)

1:14
Market Watch Rx: Zoetis Shares Slid
a month ago
by
Nicholas Jacobus

0:51
The Billions Invested in Domestic Manufacturing
a month ago
by
Mike Hollan(+1 more)

0:56
Big FDA & EMA Changes for Rare Disease Therapies
a month ago
by
Mike Hollan(+1 more)

0:53
The Challenges Bringing Pharma and Biotech Manufacturing Back to the U.S.
a month ago
by
Mike Hollan(+1 more)

0:36
Why Employers Are Blocking Obesity Drugs?
2 months ago
by
Nicholas Jacobus(+1 more)

1:04
How Novavax’s Protein-Based Vaccine Technology Works
2 months ago
by
Mike Hollan(+1 more)

1:18
Market Watch Rx: Medtronic Leads Gainers
2 months ago
by
Nicholas Jacobus

0:47
Tackling Duplicate Discounts
2 months ago
by
Michael Christel(+1 more)

0:59
Why Basket Trials Are Changing Rare Disease Research
2 months ago
by
Mike Hollan(+1 more)

1:06
Market Watch Rx: Cigna Joins Top Gainers
2 months ago
by
Nicholas Jacobus

1:13
Solving the Healthcare Cost Crisis Through Collective Action
2 months ago
by
Mike Hollan(+1 more)

1:06
Market Watch Rx: Editas Medicine Leads Gainers
2 months ago
by
Nicholas Jacobus

0:46
The First Amendment's Impact on DTC Prescription Drug Ads
2 months ago
by
Mike Hollan(+1 more)

0:38
Improving FDA & Biopharma's Relationship
2 months ago
by
Nicholas Jacobus(+1 more)

0:59
Big Pharma’s Next Big Shift: Rare Diseases vs. Mass Markets
2 months ago
by
Mike Hollan(+1 more)

1:15
Market Watch Rx: Baxter International Leads Gainers
3 months ago
by
Nicholas Jacobus

0:43
FDA's Shift: Why Predictability Now Matters More Than Speed
3 months ago
by
Mike Hollan(+1 more)

0:45
Using Data to Come to the Right Conclusions
3 months ago
by
Mike Hollan(+1 more)

1:12
Market Watch Rx: Humana Leads Top Gainers
3 months ago
by
Nicholas Jacobus
Advertisement
Advertisement
